All In MedTech

FDA Clearance Tracker · P180031-S001

Neuroform Atlas® Stent System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 30, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P180031-S001
Device name
Neuroform Atlas® Stent System
Applicant location
Fremont, CA
Received
Jul 22, 2019
Decided
Jul 30, 2020
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P180031

Device type

Device class
Class III

Every decision under product code QCA

FDA's approval statement

As written in FDA's record.

Approval for the Neuroform Atlas Stent System indicated for use with neurovascular embolization coils in the anterior and posterior circulation of the neurovasculature for the endovascular treatment of patients >= 18 years of age with saccular wide-necked (neck width >= 4 mm or a dome-to-neck ratio of < 2) intracranial aneurysms arising from a parent vessel with a diameter of >= 2.0 mm and <= 4.5 mm.

Source documents

Other decisions for Stryker Neurovascular

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.